Superoxide dismutase gene transfer reduces portal pressure in CCI 4 cirrhotic rats with portal hypertension

Gut

Volumn 58, Issue 1, 2009, Pages 118-125

  Lavina B ^a   Gracia Sancho, J ^a   Rodriguez Vilarrupla A ^a   Chu, Y ^b   Heistad, D D ^b   Bosch, J ^a   Garcia Pagan J C ^a,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF IOWA   (United States)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACETYLCHOLINE; ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CARBON TETRACHLORIDE; CYCLIC GMP; HYDROETHIDINE; NITRIC OXIDE; OXYGEN; PERCHLORATE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN CONCENTRATION; PERFUSION PRESSURE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; VEIN DILATATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WESTERN BLOTTING; ADENOVIRUS; ANIMAL; CHEMICALLY INDUCED DISORDER; EVALUATION; EXPERIMENTAL LIVER CIRRHOSIS; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; LIVER CIRCULATION; METABOLISM; METHODOLOGY; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; WISTAR RAT;

ADENOVIRIDAE; ANIMALS; CARBON TETRACHLORIDE; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HYPERTENSION, PORTAL; LIVER CIRCULATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; NITRIC OXIDE; OXYGEN CONSUMPTION; PORTAL PRESSURE; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 58249094596     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.149880     Document Type: Article

References (47)

1. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32(1 Suppl):141-56.
2. Gracia-Sancho J, Lavina 6, Rodriguez-Vilarrupla A. et al. Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers. J Hepatol 2007; 47:220-7.
3. Loureiro-Silva MR, Cadelina GW, Groszmann RJ. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol 2003; 284:G567-74.
4. Gupta TK, Toruner M, Chung MK, et al. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 1998; 28:926-31.
5. Hockey DC, Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 1998; 114:344-51.
6. 4 cirrhosis. Hepatology 2006; 44:44-52.
7. Shah V, Toruner M, Haddad F, et al. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology 1999; 117:1222-8.
8. Gracia-Sancho J, Lavina B, Rodhguez-Vilarrupla A. et al. Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability. Hepatology 2008; 47:1248-56.
9. Rodriguez-Vilarrupla A, Bosch J. Garcia-Pagan JC. Potential role of antioxidants in the treatment of portal hypertension. J Hepatol 2007; 46:193-7.
10. 4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls. Comp Hepatol 2003; 2:2.
11. Li OH, Bolli R, Qiu YM, et al. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 2001; 103:1893-8.
12. Lehmann TG, Wheeler MD, Froh M. et al. Effects of three superoxide dismutase genes delivered with an adenovirus on graft function after transplantation of fatty livers in the rat. Transplantation 2003; 76:28-37.
13. Fennell JP, Brosnan MJ, Frater AJ, et al. Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther 2002; 9:110-7.
14. Chu Y, lida S, Lund DD, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 2003; 92:461-8.
15. Zanetti M, Sato J, Katusic ZS, et al. Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. Am J Physiol Heart Circ Physiol 2001; 280:2516-23.
16. Brown KA, Chu Y, Lund DD, et al. Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. Am J Physiol Heart Circ Physiol 2006; 290:2600-5.
17. Graupera M, Garcia-Pagan JC, Titos E, et al. 5-Lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: A possible role of cysteinylleukotrienes. Gastroenterology 2002; 122:387-93.
18. Chu Y, Heistad DD. Gene transfer to blood vessels using adenoviral vectors. Methods Enzymol 2002; 346:263-76.
19. Zingarelli B, Szabo C, Salzman AL. Reduced oxidative and mtrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut 1999; 45:199-209.
20. Abraldes JG, Rodriguez-Vilarrupla A, Graupera M, et al. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCI(4) cirrhotic rats. J Hepatol 2007; 46:1040-6.
21. Peshavariya HM, Dusting GJ, Selemidis S. Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radio Res 2007; 41:699-712.
22. Graupera M, Garcia-Pagan JC, Pares M, et al. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. J Hepatol 2003; 39:515-21.
23. Hernandez-Guerra M, Garcia-Pagan JC, Bosch J. Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension. J Clin Gastroenterol 2005; 39(4 Suppl 2):S131-7.
24. Mittal MK, Gupta TK, Lee FY, et al. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994; 267(3 Pt 1):G416-22.
25. BataHer R, Gines P. Nicolas JM, et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000; 118:1149-56.
26. Hockey DC, Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 1996; 24:233-40.
27. Titos E, Claris J, Bataller R, et al. Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis. Gastroenterology 2000, 119:794-805.
28. Graupera M, Garcia-Pagan JC, Abraldes JG, et al. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology 2003; 37:172-81.
29. Garcia-Pagan JC, Bosch J. The resistance of the cirrhotic liver: a new target for the treatment of portal hypertension. J Hepatol 2004, 40:887-90
30. Van de Casteele M, Omasta A, Janssens S, et al. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats. Gut 2002; 51:440-5.
31. Shah V, Chen AF, Cao S, et al. Gene transfer of recombinant endothelial nitric oxide synthase to liver in vivo and in vitro. Am J Physiol Gastrointest Liver Physiol 2000; 279:G1023-30.
32. Yu O, Shao R, Qian HS, et al. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. J Clin Invest 2000; 105:741-8.
33. Morales-Ruiz M, Cejudo-Martin P, Fernandez-Vara G, et al. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. Gastroenterology 2003; 125:522-31.
34. Fiorucci S, Antonelli E, Morelli O, et al. NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A 2001; 98:8897-902.
35. Loureiro-Silva MR, Cadelina GW, Iwakiri Y, et al. A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats. J Hepatol 2003; 39:940-6.
36. Zafra C, Abraldes JG, Turnes J, et al. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology 2004; 126:749-55.
37. Fujimoto J, Kaneda Y. Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis. Gene Ther 1999; 6:305-6.
38. Omar BA, Flores SC, McCord JM. Superoxide dismutase: pharmacological developments and applications. Adv Pharmacol 1992; 23:109-61.
39. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001; 161:III-XIII, 1-151.
40. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, et al. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 1998; 125:1329-35.
41. Higashi T, Peters T Jr. Studies on rat liver catalase. i. combined immunochemical and enzymatic determination of catalase in liver cell fractions. J Biol Chem 1963; 238:3945-51.
42. Van de Casteele M, Hosli M, Sagesser H, et al. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats. J Hepatol 1999; 31:300-5.
43. Drazan KE, Csete ME, Da S X, et al. Hepatic function is preserved following liverdirected, adenovirus-mediated gene transfer. J Surg Res 1995; 59:299-304.
44. Yu O, Que LG, Rockey DC. Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver. Am J Physiol Gastrointest Liver Physiol 2002; 282:G565-72.
45. Nakamura T, Akiyoshi H, Saito I, et al. Adenovirus-mediated gene expression in the septal cells of cirrhotic rat livers. J Hepatol 1999; 30:101-6.
46. Garcia-Banuelos J, Siller-Lopez F, Miranda A, et al. Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion. Gene Ther 2002; 9:127-34.
47. Pizcueta MP, de Lacy AM, Kravetz D, et al. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats. Hepatology 1989; 10:953-7.